Company: MDCXW
Filing Date: 2025-06-13
Form Type: PRE 14A
Source: 0001062993-25-011673
Chunk: 39

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-13
Form: PRE 14A
Chunk 39
---
 approved in accordance with such rule."

<div align='center'>- 30 -</div>

In order to pass the Share Issuance Resolution, at least a majority of the votes cast by the Shareholders present at the Meeting in person or by proxy must be voted in favor of the Share Issuance Resolution.

THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE "" THE QUORUM AMENDMENT IN PROPOSAL 4.

<div align='center'>PROPOSAL 5 - SHARE CONSOLIDATION OR SHARE SPLIT</div>

It may at any time or from time to time prior to the next annual meeting of the Shareholders be necessary or desirable in furtherance of the Company's business objectives or capital raising activities to effect a consolidation or share split of the Company's issued and outstanding Common Shares at a consolidation or share split ratio, as the case may be, to be determined by the Board in its sole discretion (each a "Share Reorganization"). Management of the Company proposes that the Shareholders approve a special resolution authorizing the Board to approve, without further approval of the Shareholders, one or more Share Reorganizations to be effected at any time or from time to time prior to the next annual meeting of Shareholders.

Effect of Share Reorganization

If approved and implemented, each Share Reorganization will occur for all of the Company's issued and outstanding Common Shares. The Common Shares will be subject to a consolidation or share split at a consolidation or share split ratio, as the case may be, to be determined by the Board in its sole discretion.

The implementation of a Share Reorganization would not affect the total Shareholders' equity of the Company or any components of Shareholders' equity as reflected on the Company's financial statements except to change the number of issued and outstanding Common Shares to reflect such Share Reorganization.

Effect on Convertible Securities

The exercise or conversion price and/or the number of Common Shares issuable under any outstanding convertible securities, including under outstanding Options, warrants, rights, and any other similar securities will be proportionately adjusted upon the implementation of any Share Reorganization, in accordance with the terms of such securities, on the same basis as such Share Reorganization.

Certain Risks Associated with the Share Reorganization

There can be no assurance that the total market capitalization of the Company (the aggregate value of all Common Shares at the market price then in effect) immediately after any Share Reorganization will be equal to or greater than the total market capitalization immediately before such Share Reorganization